ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.733,53
0,01%
Brent Oil
81,295
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Longboard Pharmaceuticals Inc (LBPH)

  7. Longboard Pharmaceuticals Inc (LBPH) Notícias

LBPH

Longboard Pharmaceuticals (LBPH)

Longboard Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:LBPH
DataHoraFonteTítuloCódigoCompanhia
24/05/202417:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LBPHLongboard Pharmaceuticals Inc
24/05/202417:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
06/05/202417:01Business WireLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/05/202417:01Business WireLongboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/04/202410:00Business WireLongboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15NASDAQ:LBPHLongboard Pharmaceuticals Inc
12/03/202417:01Business WireLongboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/02/202410:30Business WireLongboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in FebruaryNASDAQ:LBPHLongboard Pharmaceuticals Inc
08/01/202418:05Business WireLongboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:LBPHLongboard Pharmaceuticals Inc
04/01/202418:48Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/01/202423:40Business WireLongboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common StockNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/01/202422:59Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/01/202418:01Business WireLongboard Pharmaceuticals Announces Commencement of Public Offering of Common StockNASDAQ:LBPHLongboard Pharmaceuticals Inc
02/01/202410:00Business WireLongboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)NASDAQ:LBPHLongboard Pharmaceuticals Inc
01/01/202418:47Business WireLongboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)NASDAQ:LBPHLongboard Pharmaceuticals Inc
29/11/202310:30Business WireLongboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy VolunteersNASDAQ:LBPHLongboard Pharmaceuticals Inc
21/11/202318:00Business WireLongboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy CommunityNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/11/202317:01Business WireLongboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/11/202317:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/11/202317:01Business WireLongboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/11/202309:30Business WireLongboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in NovemberNASDAQ:LBPHLongboard Pharmaceuticals Inc
05/10/202317:05Business WireLongboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023NASDAQ:LBPHLongboard Pharmaceuticals Inc
19/09/202309:30Business WireLongboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023NASDAQ:LBPHLongboard Pharmaceuticals Inc
31/08/202317:00Business WireLongboard Pharmaceuticals to Participate in Three Upcoming Investor ConferencesNASDAQ:LBPHLongboard Pharmaceuticals Inc
30/08/202317:01Business WireLongboard Pharmaceuticals to Present Data at Upcoming Medical MeetingsNASDAQ:LBPHLongboard Pharmaceuticals Inc
23/08/202309:30Business WireLongboard Pharmaceuticals Completes Enrollment of Phase 1b/2a PACIFIC Study Evaluating LP352 for the Treatment of Developmental and Epileptic EncephalopathiesNASDAQ:LBPHLongboard Pharmaceuticals Inc
14/08/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LBPHLongboard Pharmaceuticals Inc
04/08/202317:10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/08/202317:01Business WireLongboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/08/202309:30Business WireLongboard Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:LBPHLongboard Pharmaceuticals Inc
26/06/202317:00Business WireLongboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023NASDAQ:LBPHLongboard Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:LBPH

Seu Histórico Recente

BOV
BBDC4
BRADESCO PN
BOV
GFSA3
GAFISA ON
COIN
XLMBTC
Stellar Lumens
BOV
ELET6
ELETROBRAS PNB
COIN
PLUS1BTC
PlusOneCoin
COIN
BRAZBTC
Brazio
COIN
XRPBTC
Ripple
COIN
LTCUSD
Litecoin
COIN
BCHBTC
Bitcoin Cash
EU
PX1
CAC 40
COIN
BTCUSD
Bitcoin
BOV
VALE3
VALE ON
COIN
ETHUSD
Ethereum
BOV
PETR3
PETROBRAS ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados